Allen Ciuffo, MD
Cardiovascular Disease · Norfolk, VANPI 1649243502
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,663 of the $3,851 with a category attached, or 69.2%. Boston Scientific accounts for 87.8% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $1,762 and has fallen 90.3% since, to $172 in 2025.
Across 52 payments — averaging $74.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Medtronic$188
- Abiomed$140
- Cvrx, Inc.$118
- Abbott$23
Across 53 payments — averaging $4467.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$205K
- Abbott$17K
- Medtronic$15K
What the payments were for
- Travel & lodging$2,66369%
- Food & beverage$1,18831%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 46 | $3,380 |
| Medtronic | 3 | $188 |
| Abiomed | 1 | $140 |
| Cvrx, Inc. | 1 | $118 |
| Abbott | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$1,447
- Impella$140
- Barostim Neo System$118
- COBALT DR MRI SURESCAN$107
How this compares
$3,851 in reported general payments places this provider in the 70th percentile of 548 cardiovascular disease providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 47 | $69,630 |
| Metoprolol Succinate | 40 | $822 |
| Carvedilol | 48 | $469 |
| Warfarin Sodium | 29 | $433 |
| Rosuvastatin Calcium | 22 | $343 |
| Atorvastatin Calcium | 27 | $321 |
| Nitroglycerin | 13 | $289 |
| Furosemide | 42 | $268 |
| ClopidogrelClopidogrel Bisulfate | 12 | $233 |
| Lisinopril | 35 | $196 |
| Losartan Potassium | 18 | $150 |
| Spironolactone | 11 | $95 |
| Metoprolol Tartrate | 26 | $75 |
| Sildenafil Citrate | 15 | $68 |
| Amlodipine Besylate | 11 | $22 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Norfolk
- Cyrus HadadiNorfolk$360K
- Keith NewbyNorfolk$90K
- Joshua CohenNorfolk$78K
- George VetrovecRichmond$2.3M
- Hamid TaheriManassas$501K
- Michael AyersCharlottesville$305K
- David LimCharlottesville$264K
- Alexander TruesdellFalls Church$167K
- Antonio AbbateCharlottesville$161K
- Christopher OconnorFalls Church$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.